Phase 1 Biliary Dyskinesia Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Food-Effect, Single and Multiple Dose Pharmacokinetics, Safety and Tolerability Study of 4-MUST, 128 mg, Tablets in Healthy Volunteers

Biliary DyskinesiaChronic Cholecystitis

Valenta Pharm JSC45 enrolled1 locationNCT07594977

Recruiting

Phase 1

Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.

Gallstone DiseaseIrritable Bowel SyndromeGERD+2 more

Valenta Pharm JSC36 enrolled1 locationNCT07421011